SLITRK6 and colorectal carcinoma: Statistically significant results include the 7.16-fold upregulation of L1TD1 in CRC N+ (p = 0.008) and 6.16-fold downregulation of SLITRK6 (p = 0.039) and 3.10-fold for ST6GALNAC1 (p = 0.02) in CRC N+.